Platform Technology Partners’s Matinas BioPharma MTNB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,125	Closed	-$24.7K	–	232
2024 Q2	$24.7K	Buy	+3,125	New	+$28.3K	0.01%	222
2023 Q4	$33K	Sell	3,125 -123	-4%	-$1.39K	0.01%	199
2023 Q3	$21.1K	Hold	3,248	–	–	0.01%	196
2023 Q2	$64.1K	Hold	3,248	–	–	0.03%	193
2023 Q1	$76.3K	Hold	3,248	–	–	0.04%	189
2022 Q4	$81.2K	Hold	3,248	–	–	0.04%	186
2022 Q3	$103K	Buy	3,248 +400	+14%	+$15.7K	0.06%	171
2022 Q2	$113K	Hold	2,848	–	–	0.06%	177
2022 Q1	$115K	Sell	2,848 -375	-12%	-$13.8K	0.06%	191
2021 Q4	$163K	Sell	3,223 -80	-2%	-$4.28K	0.07%	195
2021 Q3	$215K	Sell	3,303 -520	-14%	-$22.4K	0.1%	192
2021 Q2	$148K	Buy	+3,823	New	+$164K	0.06%	233
2020 Q4	$216K	Sell	3,173 -210	-6%	-$9.72K	0.11%	192
2020 Q3	$130K	Buy	3,383 +483	+17%	+$19.2K	0.08%	183
2020 Q2	$112K	Buy	2,900 +900	+45%	+$34.5K	0.08%	181
2020 Q1	$60K	Hold	2,000	–	–	0.05%	163
2019 Q4	$227K	Buy	+2,000	New	+$116K	0.17%	150